Back to search

Article

A PBPK Digital Twin of Rapamycin for Predicting Dose–Exposure Relationships, Organ Impairment Effects, and Drug–Drug Interactions

2026-05-06

Abstract excerpt

Sirolimus is a potent mTOR inhibitor used primarily to prevent acute rejection in transplant recipients. Its clinical management is challenging because of its narrow therapeutic index, low and highly variable oral bioavailability, and pronounced inter-individual variability driven by CYP3A4/5-mediated metabolism and P-glycoprotein efflux. Extensive partitioning into erythrocytes further complicates its disposition...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b4c15ad1-b900-515d-b9d2-23f91f0543f4
DOI
10.20944/preprints202605.0328.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A PBPK Digital Twin of Rapamycin for Predicting Dose–Exposure Relationships, Organ Impairment Effects, and Drug–Drug InteractionsDOI 10.20944/preprints202605.0328.v1
Select a neighboring publication to make it the new centre.